Ignite Creation Date:
2025-12-25 @ 4:23 AM
Ignite Modification Date:
2025-12-26 @ 3:25 AM
Study NCT ID:
NCT04923620
Status:
RECRUITING
Last Update Posted:
2024-02-26
First Post:
2021-06-06
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Neoadjuvant Cetuximab + Chemotherapy Combined With Short-course Radiotherapy
Sponsor:
Shanghai Minimally Invasive Surgery Center
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-10-20
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-06
Completion Date Type:
ESTIMATED
First Submit Date:
2021-06-06
First Submit QC Date:
None
Study First Post Date:
2021-06-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-22
Last Update Post Date:
2024-02-26
Last Update Post Date Type:
ACTUAL